Michael D. Taylor

发表

Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials

William B. Capra, Ryan Copping, K. Rothman, 2019, Clinical pharmacology and therapeutics.

A Comparison of the Effectiveness of First-Line Chemoimmunotherapy Regimens for Follicular Lymphoma (FL) Used in the United States

J. Cerhan, J. Friedberg, C. Flowers, 2011 .

Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.

J. Cerhan, A. Zelenetz, J. Friedberg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database

S. Griffith, Aracelis Z. Torres, Michael D. Taylor, 2019, Pharmacoepidemiology and drug safety.

Validation of diagnosis codes to identify side of colon in an electronic health record registry

P. Luhn, N. Meropol, D. Kuk, 2017, BMC Medical Research Methodology.

Real-world (RW) characteristics, treatment (tx) patterns, and overall survival (OS) in US patients (pts) with metastatic breast cancer (mBC) and CNS metastases (CNS mets).

Michael D. Taylor, D. Heinzmann, A. Shewade, 2018 .

Examining the Outcomes of Watchful Waiting (WW) Among US Patients with Advanced Stage Follicular Lymphoma (FL)

J. Cerhan, J. Friedberg, C. Flowers, 2011 .

Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma.

E. M. Warton, M. Asgari, C. Quesenberry, 2014, Journal of the American Academy of Dermatology.

External Comparator Groups Derived from Real-world Data Used in Support of Regulatory Decision Making: Use Cases and Challenges

K. Rothman, M. Brookhart, B. Bradbury, 2022, Current Epidemiology Reports.

Racial Disparities in Disease Presentation, Treatment, and Response Rates of Follicular Lymphoma (FL) in the United States (US): Report From the National LymphoCare Study (NLCS).

C. Flowers, C. Nabhan, Michael D. Taylor, 2009 .

Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

Sandra D Griffith, Rebecca A Miksad, Geoff Calkins, 2019, JCO clinical cancer informatics.

Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era

J. Cerhan, J. Friedberg, C. Flowers, 2016, British journal of haematology.

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States

J. Cerhan, J. Friedberg, C. Flowers, 2015, Leukemia & lymphoma.

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States

J. Cerhan, J. Friedberg, C. Flowers, 2014, Cancer.

Follicular lymphoma in the United States: first report of the national LymphoCare study.

J. Cerhan, J. Vose, A. Zelenetz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

A. Abernethy, S. Griffith, Michael D. Taylor, 2018, Health Services Research.

Racial differences in presentation and management of follicular non‐Hodgkin lymphoma in the United States

J. Cerhan, J. Friedberg, C. Flowers, 2012, Cancer.

Disease Characteristics and Patterns of Care In Elderly Patients (80+ years) with Follicular Lymphoma (FL) In the United States (US); Are Older Patients Treated Differently? Report From the National LymphoCare Study (NLCS)

C. Flowers, C. Nabhan, Michael D. Taylor, 2010 .

Patterns of Care in Follicular Lymphoma (FL): Are Minorities Being Treated Differently? Report from the National LymphoCare Study (NLCS).

J. Hainsworth, C. Nabhan, Michael D. Taylor, 2007 .

Correlates of Treatment Intensity for Initial Management of Follicular Lymphoma (FL) in the United States: Report from the National Lymphocare Study (NLCS).

J. Vose, E. Chrischilles, B. Link, 2007 .

A systematic approach towards missing lab data in electronic health records: A case study in non-small cell lung cancer and multiple myeloma.

Michael D. Taylor, M. Samant, J. Weberpals, 2023, CPT: pharmacometrics & systems pharmacology.

Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study.

J. Cerhan, A. Zelenetz, J. Friedberg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era

J. Cerhan, J. Friedberg, C. Flowers, 2016, British journal of haematology.

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

J. Cerhan, A. Zelenetz, J. Friedberg, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.